Trial NCT04508075 ; INA-WXFM0YX
Publication Fadlyana E, Vaccine, 2021
Primary outcome on the report: Incidence of laboratory confirmed-symptomatic COVID-19 cases starting at 14 days following the second dose

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.